Search clinical trials for: Vardenafil HCl (Levitra, BAY38-9456)

Total 65 results

Bayer

Completed

A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function

Overactive Bladder | Detrusor Overactivity

Spain, Belgium, Canada, Netherlands, Switzerland, Russian Federation, Germany, Israel, Hungary, Portugal, France, Poland, Czech Republic
Bayer

Completed

LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers

Erectile Dysfunction

Japan
Bayer
GlaxoSmithKline

Completed

Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer

Completed

A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy. (FINDER)

Erectile Dysfunction

Belgium, Finland, Germany, France, Denmark, United Kingdom, Spain
Bayer

Completed

Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours

Erectile Dysfunction
Bayer

Completed

Depression Related Improvement With Vardenafil for Erectile Response (DRIVER)

Depression | Erectile Dysfunction

Italy, Spain, France, United States, Canada
Bayer

Completed

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

Erectile Dysfunction

Hong Kong, Malaysia, Singapore, Thailand, Philippines, Indonesia
Bayer

Terminated

Real Life Safety and Efficacy of Vardenafil

Erectile Dysfunction

Taiwan
Bayer
GlaxoSmithKline

Completed

Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

United States, Canada
Bayer
GlaxoSmithKline

Completed

Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia

Erectile Dysfunction
Bayer

Completed

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice (REVITALISE)

Erectile Dysfunction

Korea, Republic of, Saudi Arabia, Singapore, Kazakhstan, Lebanon, Russian Federation, Ukraine, Egypt, Israel, Kyrgyzstan
Bayer
GlaxoSmithKline

Completed

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

Erectile Dysfunction

Turkey
Bayer

Completed

A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

Spain, Italy, Canada, United States, Germany, Poland, France, Netherlands, Norway, Sweden, United Kingdom
Bayer

Completed

A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction

Erectile Dysfunction

United Kingdom, Ireland
Bayer

Completed

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

Germany
Bayer

Completed

Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction

Erectile Dysfunction

Germany
Bayer

Completed

REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy

Erectile Dysfunction

Poland, China, Croatia, France, Germany, Hungary, Indonesia, Korea, Republic of, Malaysia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Thailand
Bayer

Completed

BAY38-9456 - Pivotal Trial for Diabetes Patient

Diabetes Mellitus | Erectile Dysfunction
Bayer

Completed

Vardenafil in Tinnitus

Tinnitus

Germany
Bayer

Completed

LEVITRA® 20mg Special Drug Use Investigation (Long-term)

Erectile Dysfunction

Japan
Bayer

Completed

Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men

Erectile Dysfunction

Poland
Bayer
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

Erectile Dysfunction
Bayer

Completed

Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome

Metabolic Syndrome | Erectile Dysfunction

Germany
Bayer
GlaxoSmithKline

Completed

Assessment of Duration of Erection With Vardenafil 10 mg

Erectile Dysfunction
Bayer

Completed

Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction

Erectile Dysfunction

Spain
Bayer
Amgen

Completed

Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction

Erectile Dysfunction

Russian Federation
Bayer

Completed

BAY38-9456 - Supportive Trial for Spinal Injury

Sexual Dysfunction | Erectile Dysfunction | Spinal Cord Injury

Japan
Bayer

Completed

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Prostatic Hypertrophy, Benign

Germany
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension

Erectile Dysfunction
Bayer

Completed

To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.

Erectile Dysfunction

India
Bayer
GlaxoSmithKline

Completed

Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil

Erectile Dysfunction
Bayer

Completed

Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED

Erectile Dysfunction | Sexual Dysfunction, Physiological

Belgium, Italy, Spain, France, Switzerland, Canada, Sweden, Austria, United States, Germany, United Kingdom, South Africa, Netherlands, Norway, Finland
Bayer

Completed

Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)

Erectile Dysfunction

United States
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse

Erectile Dysfunction
Bayer

Completed

BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.

Erectile Dysfunction

China
Bayer

Completed

Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks

Erectile Dysfunction
Bayer

Completed

Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II

Sexual Dysfunction | Male Erectile Dysfunction

Belgium, Italy, France, Germany, Spain, Netherlands, South Africa
Bayer

Completed

Levitra® - Real Life Safety and Efficacy of Levitra (REALISE)

Erectile Dysfunction
Bayer

Completed

Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction

Erectile Dysfunction
Bayer
GlaxoSmithKline

Completed

Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)

Erectile Dysfunction
Bayer

Completed

Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia (LUTECIA)

Erectile Dysfunction

Israel, Italy, Colombia, Spain, Belgium, Finland, Mexico, Germany, South Africa, Netherlands, Norway, Peru, Sweden
Bayer

Completed

A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction (VIS)

Erectile Dysfunction
Bayer

Completed

Assess Efficacy in Subjects With Traumatic Spinal Cord Injury (LEMDE)

Erectile Dysfunction | Spinal Cord Injury

Spain
Bayer

Completed

Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function

Erectile Dysfunction

United States
Bayer
GlaxoSmithKline

Completed

FDA Phase IV - Commitment - Retinal Function Study

Safety
Bayer
GlaxoSmithKline; Schering-Plough

Completed

Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction

Erectile Dysfunction

Belgium, Spain, Germany, South Africa, France, Netherlands

3

Subscribe